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Paragangliomas are extra-adrenal tumors of the autonomic nervous system and may be found within the skull base, neck, chest,
and abdomen. When presenting within the abdominal cavity, they may arise as a primary retroperitoneal neoplasm and can
mimic vascular malformations or other conditions related to speciﬁc retroperitoneal organs such as the pancreas, kidneys, or
adrenals. Retroperitoneal paragangliomas are mostly benign with good prognosis; however, they can present with abdominal pain,
palpable mass, or hypertensive episodes. Patients should be initially evaluated with catecholamine levels, followed by computed
tomography or magnetic resonance imaging to locate the primary lesion. Surgical excision remains the mainstay of treatment,
although advanced disease and proximity to vital organs can make excision diﬃcult or impossible. This case report describes
a patient who initially underwent work up for a suspected pancreatic head mass which was discovered to be a retroperitoneal
paraganglioma by frozen section.
1.Introduction
Paragangliomas are extra-adrenal tumors of the autonomic
nervous system and may be found within the skull base,
neck, chest, and abdomen. When presenting within the
abdomen, they may arise as a primary retroperitoneal
neoplasm and can be mistaken for other retroperitoneal
tumors, including those arising from the pancreas. This
case report describes a patient who initially underwent
work up for a suspected pancreatic head mass which was
discovered to be a paraganglioma by frozen section. In
addition, a review of current literature was performed
summarizing radiographic and clinical ﬁndings associated
with retroperitoneal paragangliomas.
2.CaseReport
This is a 50-year-old white male who originally presented
in 2004 with complaints of epigastric abdominal pain. The
patient’s past medical history was signiﬁcant for hyperten-
sion, 30-pack per-year history of tobacco use, occasional
ETOH use, diabetes, hyperlipidemia, and regular marijuana
use.Workupatthattimerevealedelevatedamylaseandlipase
levels, a dedicated gallbladder ultrasound was unremarkable,
and the ﬁnal diagnosis of thiazide-induced pancreatitis was
made. The medication was discontinued, laboratory values
normalized, and the patient was discharged. The patient pre-
sented again in 2005 with similar complaints and lab abnor-
malities. Upon questioning, the patient stated he continued2 HPB Surgery
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Figure 1:AxialnoncontrastCTabdomendemonstratesaretroperi-
toneal soft tissue lesion (arrowheads) with lobulated margins and a
central calciﬁcation. Prominent vessels are noted around the lesion.
The second duodenal portion contacts the mass (arrow).
his thiazide medication since prior discharge; the thiazide
was again discontinued. Following clinical improvement the
patient was discharged and switched to an ACE inhibitor
for blood pressure management. In the outpatient clinical
setting, the patient continued to have unresolved epigastric
abdominal discomfort despite unremarkable amylase and
lipase values. In light of this, a computed tomography (CT)
scan of the abdomen and pelvis was performed in early
2006 demonstrating a hypervascular retroperitoneal mass
intimately related to the pancreas (Figures 1, 2,a n d3).
A positron emission tomography (PET) scan performed
7/2006 demonstrated intense FDG uptake in the region of
the pancreatic head without locoregional nodal or distant
metastatic disease. Fine needle aspiration of the mass was
suggestive of poorly diﬀerentiated carcinoma. These ﬁndings
prompted surgical consultation and a Whipple procedure
was planned for resection of the possible pancreatic head
mass. In 8/2006 surgical exploration revealed a retroperi-
toneal mass situated inferior to the uncinate process which
extended to the infrarenal abdominal aorta. The mass
demonstrated close involvement with the inferior vena
cava and superior mesenteric vessels. Direct involvement of
the pancreas and adrenals was not appreciated. Given the
unusual location of the mass as well as its aortic proximity,
resection was deferred.
A true cut biopsy was performed and sent for frozen as
well as permanent section analysis. Histologic examination
revealedawell-circumscribedneoplasmcomposedofepithe-
lioid chief cells with eosinophilic cytoplasm arranged in a
nestedpatternandperipherallysurroundedbymorespindle-
shaped sustentacular cells. These cell nests, referred to as
“zellballen”, are characteristic of paragangliomas (Figure 4).
The neoplasm was histologically benign, with minimal
pleomorphism, no evidence of invasion, and low mitotic
activity. Frozen section diagnosis was rendered as “consis-
tent with paraganglioma”. Immunohistochemical stains on
the permanent section specimen, including chromogranin,
Figure 2: Axial contrast enhanced CT abdomen shows a hypervas-
cularretroperitonealmass(arrowheads)withenlargedsurrounding
vessels (large arrow). No cleavage plane is noted between the
duodenum and the mass (short arrow). Also the mass contacts the
inferior vena cava (IVC).
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Figure 3: Contrast enhanced CT abdomen. Curved multiplanar
reconstruction demonstrates an intimal relation of the retroperi-
toneal paraganglioma, and the proximal pancreas, duodenum (d),
and IVC. Pancreatic body and tail show parenchymal atrophy and
pancreatic ductal dilatation (arrows). SMA: superior mesenteric
artery.
synaptophysin, and S100, conﬁrmed the neuroendocrine
origin of this neoplasm (Figure 5) .A sar e s u l t ,aﬁ n a l
pathologic diagnosis of “extraadrenal paraganglioma” was
issued.
The patient underwent radiation treatment receiving
a total dose of 3960 gray divided into 22 fractions from
October 17, 2006 to November 16, 2006. Repeat CT imaging
2/2007 demonstrated no signiﬁcant interval change of theHPB Surgery 3
Figure 4: Paraganglioma composed of dual cell population
arranged in characteristic nested pattern “zellballen” (20x).
Figure 5: Synaptophysin (brown immunohistochemical stain)
conﬁrms neuroendocrine origin, supporting the diagnosis of
paraganglioma (20x).
paraganglioma. Follow-up CT 7/2007 showed continued sta-
bility. Repeat PET 7/2007 demonstrated the retroperitoneal
paraganglioma minimally smaller compared to 7/2006. On
surveillanceCTimaging5/2008thepatientwasnotedtohave
asolidleftrenallesionwithoutevidenceofdistantmetastasis.
After consultation with Urology the patient underwent a
partial left nephrectomy in 7/2008. Frozen diagnosis was
positive for renal cell carcinoma with a negative surgical
margin. Surveillance CT imaging on 9/2009 demonstrated
a mildly smaller retroperitoneal paraganglioma without
evidenceofrecurrenceorspreadofeitherprimary(Figure 6).
3. Discussion
Primary ret roperitoneal neoplasms are rare benign and
malignant mesenchymal tumors that arise in the retroperi-
toneum, outside of the major organs [1]. Paragangliomas
are extra-adrenal pheochromocytomas that arise from chro-
maﬃn cells in the sympathetic (localized in retroperitoneum
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Figure 6:AxialcontrastenhancedCTabdomen.Twoyearsimaging
follow-up shows interval decrease in size of the paraganglioma.
Perilesional fat stranding is related to prior surgical procedure and
radiation therapy (arrowhead).
and thorax) or parasympathetic (next to aortic arch, neck,
and skull base) neural paraganglia [2]. They account for
10% of adult pheochromocytomas. About 70% of sym-
pathetic paragagliomas are intraabdominal, usually found
in the perinephric and paraaortic spaces. The remaining
30% are located in the chest. Malignant retroperitoneal
paragangliomasrangefrom30%to50%[3].Paragangliomas
metastasize approximately in 20% to 42% of the cases. Dis-
semination can be hematogenous or through the lymphatic
system, with the most common site of metastasis being the
regional lymph nodes, bone, lung, and liver. Because benign
and malignant paragangliomas have the same histological
appearance, the best predictor for outcome is metastasis or
recurrence [2].
Functional paragangliomas secrete norepinephrine and
normetanephrine and account for 30–60% of the tumors
[3]. If a secretory tumor is present, the patients undergo
paroxysmal episodic hypertension, as well as the typical triad
of symptoms associated with pheochromocytomas: palpi-
tations, headache, and profuse sweating. The nonsecretory
type most commonly presents as abdominal pain or mass
[4]; a large proportion of these tumors are incidentally dis-
covered in normotensive patients during imaging evaluation
for other reasons [5].
The diagnosis is usually established with high urine
catecholamine metabolites, VMA, and metanephrine levels
[4]. Once the diagnosis of chromaﬃn tumor is established,
the next step is to determine the extension of the disease. The
imaging modality of choice for primary tumor evaluation
and staging is a CT of the thorax, abdomen, and pelvis. If no
lesion is found, further imaging of the organ of Zuckerland
and the bladder is performed. CT imaging demonstrates
93–100% sensitivity for localizing adrenal tumors, and
90% for extra-adrenal tumors [4]. On CT, retroperitoneal
paraganglioma appears as a hypervascular mass. Areas of
intralesional hemorrhage and necrosis can be frequently4 HPB Surgery
seen as the tumor enlarges. They are commonly located
in the para-aortic region, and they may be confused with
other retroperitoneal tumors, especially pancreatic tumors
(Figure 3)[ 6]. MRI is more sensitive than CT in detecting
extra-adrenal tumors. Scintigraphy with 123-I labeled MIBG
oﬀers superior speciﬁcity than CT and MRI imaging [2].
Genetic disorders involving mutations within the suc-
cinate dehydrogenase B and D units (SDHB, SDHD) and
the von Hippel-Lindau (VHL) gene places an increased risk
in the development of extra-adrenal paragangliomas and
adrenal pheochromocytomas, respectively [7]. Development
of additional primary neoplasms has also been described,
including renal cell carcinoma and thyroid cancers [8].
The possibility for malignant transformation of para-
gangliomas makes surgical excision the treatment of choice.
Radiation therapy has been advocated for patients who
cannot undergo surgery or for unresectable tumors [7].
Aggressive surgery is mandatory to obtain disease free
survival. Therapy with radionucleotides may be used for
tumors exhibiting uptake on diagnostic scan [4]. Octreotide
can be used for treatment of inoperable paragangliomas [9].
Tumor recurrences can also be successfully excised surgically
with low morbidity [10].
In conclusion, retroperitoneal paragangliomas are rare
tumors, mostly benign with good prognosis, but can be
locally invasive and metastasize as well. They can present
with pain, mass or hypertensive episodes. Patients should
be initially evaluated with catecholamine levels, followed by
CT or MRI to locate the primary lesion. Surgical excision
remains the mainstay of treatment, although advanced
diseaseandprominentvascularitycanattimesmakeexcision
diﬃcult or impossible.
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